Disease | Gene | OMIM | TAT in weeks |
---|---|---|---|
Zellweger syndrome | |||
NGS | 4-8 | ||
Zinc deficiency | |||
CDK13 | CDK13 | NULL | |
CHGA | CHGA | NULL | |
CTBP1 | CTBP1 | NULL | |
FOXA2 | FOXA2 | NULL | |
MACF1 | MACF1 | NULL | |
PCDH12 | PCDH12 | NULL | |
PCM1 | PCM1 | ||
PTCHD1 | PTCHD1 | NULL | |
RREB1 | RREB1 | NULL | |
SHANK2 | SHANK2 | NULL | |
TANC2 | TANC2 | 2-4 | |
TRIP12 | TRIP12 | NULL | |
NULL | |||
HMGCL | HMGCL | 4-6 | |
3-methylcrotonyl-CoA carboxylase 1 deficiency | MCCC1 | MCCC1 | 2-4 |
3-methylcrotonyl-CoA carboxylase 1/2 deficiency | MCCC1, MCCC2 | MCCC1, MCCC2 | 4-8 |
type 1 | AUH | AUH | 2-4 |
3M syndrome | CCDC8 | CCDC8 | 2-4 |
3M syndrome | CUL7 | CUL7 | 2-4 |
3M syndrome | OBSL1 | OBSL1 | 2-4 |
3MC syndrome | MASP1 | MASP1 | 5-6 |
abetalipoproteinemia | MTP | MTP | 4-6 |
NGS | CNGA3, CNGB3, GNAT2, PDE6C, ATF6 | CNGA3,CNGB3,GNAT2,PDE6C,ATF6 | 4-6 |
type 2 | CNGA3 | CNGA3 | 3-4 |
type 3 | CNGB3 | CNGB3 | 3-4 |
type 4 | GNAT2 | GNAT2 | 3-4 |
- | GLI3 | GLI3 | 3-5 |
- | GLI3 | GLI3 | 2-3 |
GLI3, KIF7 | GLI3, KIF7 | NULL | |
acrodermatitis enteropathica | SLC39A4 | SLC39A4 | 3-4 |
DLL4 | DLL4 | 2-4 | |
DOCK6 | DOCK6 | 2-4 | |
ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ | ARHGAP31, DLL4, DOCK6, EOGT, NOTCH1, RBPJ | 4-8 | |
ERIS | ERIS | 4-5 | |
type 7 | TMC1 | TMC1 | 4-5 |
X-linked | ABCD1 | ABCD1 | 2-4 |
ADTKD | NULL | ||
GNAS | GNAS | 2-4 | |
Alexander syndrome | GFAP | GFAP | 4-6 |
alkaptonuria | HGD | HGD | 2-4 |
Alpha-ketoglutarate dehydrogenase deficiency | OGDH | OGDH | 3-5 |
4-6 | |||
IGFALS | IGFALS | 2-4 | |
Alzheimer disease | APP, PSEN1, PSEN2, apoE4 | APP, PSEN1, PSEN2, apoE4 | 4-8 |
Alzheimer disease | APP | APP | 4-8 |
Alzheimer disease | PSEN1 | PSEN1 | 4-8 |
TARDBP | TARDBP | 3-4 | |
SEPTIN9 | SEPTIN9 | ||
Anderman syndrome | SLC12A6 | SLC12A6 | NULL |
androgen insensitivity syndrome | AR | AR | 2-4 |
androgen insensitivity syndrome | AR | AR | 2-4 |
hemolytic | CD59 | CD59 | 2-4 |
- | SEC23B | SEC23B | 2-4 |
NGS | CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B | CDAN1, CDIN1, KLF1, KIF23, GATA1, SEC23B | 4-6 |
type 1 | CDAN1 | CDAN1 | 2-4 |
PAX6, WT1, SOX2 | PAX6, WT1, SOX2 | 2-4 | |
ANK3 | ANK3 | ||
anticoagulant sensitivity | CYP4F2 | CYP4F2 | 2-3 |
anticoagulant sensitivity | VKORC1 | VKORC1 | 2-3 |
antithrombin 3 deficiency | SERPINC1 | SERPINC1 | 4-6 |
NGS | 4-6 | ||
Apert syndrome | FGFR2 | FGFR2 | 2-3 |
- | FOXD3 | FOXD3 | 2-4 |
- | FOXE3 | FOXE3 | 2-4 |
apparent mineralocorticoid excess | HSD11B2 | HSD11B2 | 2-4 |
argininosuccinic aciduria | ASL | ASL | 2-4 |
DZIP1L | DZIP1L | NULL | |
PKHD1L1 | PKHD1L1 | 4-6 | |
4-6 | |||
4-6 | |||
4-6 | |||
4-6 | |||
4-6 | |||
Ashkenazi Jewish panel | 7-8 | ||
Ashkenazi Jewish panel | 7-8 | ||
oculomotor apraxia type 1 | APTX | APTX | 6-8 |
ataxia with vitamin E deficiency | TTPA | TTPA | 5-6 |
HARS2 | HARS2 | 2-4 | |
autosomal dominant, type 1 | DIAPH3 | DIAPH3 | 4-5 |
autosomal-recessive, type 59 | DFNB59 | DFNB59 | 2-4 |
NLGN1 | NLGN1 | ||
PTPN4 | PTPN4 | ||
type 1 | FAS | FAS | 2-4 |
type 1 | FASLG/FASL | FASLG/FASL | 2-4 |
type 2B | CASP8 | CASP8 | 2-4 |
type 3 | PRKCD | PRKCD | 2-4 |
type 1 | ACTB | ACTB | 2-4 |
type 2 | ACTG1 | ACTG1 | 2-4 |
Methylation analysis H19-DMR and KvDMR1 | H19, KCNQ1OT1 | H19,KCNQ1OT1 | 2-4 |
sequence analysis CDKN1C | CDKN1C | CDKN1C | 4-6 |
sequence analysis CDKN1C | CDKN1C | CDKN1C | 2-4 |
sequence analysis NLRP2 | NLRP2 | NLRP2 | 2-4 |
KCNQ3 | KCNQ3 | NULL | |
- | GP1BB | GP1BB | 4-6 |
beta-propeller protein-associated neurodegeneratio | WDR45 | WDR45 | 2-4 |
Bietti crystalline corneoretinal dystrophy | CYP4V2 | CYP4V2 | 4-6 |
NULL | |||
SLC19A3 | SLC19A3 | 2-4 | |
BTD | BTD | NULL | |
FLCN | FLCN | ||
- | DICER1 | DICER1 | 4-8 |
- | DICER1 | DICER1 | 4-8 |
autosomal dominant | FOXL2 | FOXL2 | 2-4 |
Bloom syndrome | BLM | BLM | 3-4 |
Bloom syndrome | 8-10 | ||
- | OPN1LW | OPN1LW | 3-4 |
- | OPN1MW | OPN1MW | 3-4 |
2-3 | |||
type 1 | FKBP10 | FKBP10 | 2-4 |
type 2 | PLOD2 | PLOD2 | 2-4 |
Brunner syndrome | MAOA | MAOA | 6-8 |
TXNL4A | TXNL4A | 2-4 | |
butyrylcholinesterase deficiency | BCHE | BCHE | 4-5 |
Börjeson-Forssman-Lehmann syndrome | PHF6 | PHF6 | 2-4 |
CACH syndrome | EIF2B1 | EIF2B1 | 3-4 |
CACH syndrome | EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 | EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5 | 6-8 |
CACH syndrome | EIF2B2 | EIF2B2 | 4-5 |
CACH syndrome | EIF2B3 | EIF2B3 | 4-5 |
CACH syndrome | EIF2B4 | EIF2B4 | 4-5 |
CACH syndrome | EIF2B5 | EIF2B5 | 4-5 |
Caffey disease | COL1A1 | COL1A1 | 4-6 |
Caffey disease | COL1A1 | COL1A1 | 2-3 |
4-8 | |||
NGS | TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF | TP53, KRAS, MYC, ARID1A, PTEN, EGFR, SMARCA4, RICTOR, MLL2/KMT2D, BRAF | 2 |
carbamoylphosphate synthetase 1 deficiency | CPS1 | CPS1 | 2-4 |
- | MYBPC3 | MYBPC3 | 2-4 |
NGS | DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere | DES, DSP, LMNA, MYH7, MYBPC3, TNNT2, ACTN2 und weitere | 4-6 |
NGS | ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 | ACTC1, DTNA, LDB3, LMNA, MIB1, MYBPC3, MYH7, PRDM16, TAZ, TNNT2, TPM1 | 4-6 |
type 1 | PRKAR1A | PRKAR1A | 4-6 |
- | SLC22A5 | SLC22A5 | 2-4 |
type 2 | CPT2 | CPT2 | 2-4 |
type 1A | CPT1A | CPT1A | 2-4 |
LC25A20 | LC25A20 | 2-4 | |
cartilage-hair hypoplasia | RMRP | RMRP | 2-3 |
DSP | DSP | 2-4 | |
type 6 | EPHA2 | EPHA2 | 2-4 |
NHS | NHS | 2-4 | |
type 17 | CRYBB1 | CRYBB1 | 2-4 |
type 2 | CRYGC | CRYGC | 2-4 |
type 3 | CRYBB2 | CRYBB2 | 2-4 |
type 31 | CHMP4B | CHMP4B | 2-4 |
type 4 | CRYGD | CRYGD | 2-4 |
type 9 | CRYAA | CRYAA | 2-4 |
Catechol-O methyltransferase activity | COMT | COMT | 2-3 |
CDH10 | CDH10 | ||
cerebral cavernous malformations | KRIT1, CCM2, PDCD10 | KRIT1, CCM2, PDCD10 | 4-8 |
Chanarin-Dorfman syndrome | ABHD5 | ABHD5 | 4-8 |
dominant intermediate B | DNM2 | DNM2 | 3-4 |
dominant intermediate D | MPZ | MPZ | 4-5 |
type 1A | PMP22 | PMP22 | 2-3 |
type 1B | MPZ | MPZ | 3-4 |
type 1C | LITAF | LITAF | 3-4 |
type 1D | EGR2 | EGR2 | 3-4 |
type 1E | PMP22 | PMP22 | 3-4 |
type 2A | MFN2 | MFN2 | 3-4 |
type 2F | HSPB1 | HSPB1 | 3-4 |
type 2H | GDAP1 | GDAP1 | 3-4 |
type 2I | MPZ | MPZ | 3-4 |
type 2J | MPZ | MPZ | 4-5 |
type 2K | GDAP1 | GDAP1 | 3-4 |
type 2N | AARS | AARS | NULL |
type 2O | DYNC1H1 | DYNC1H1 | 2-4 |
type 2U | MARS | MARS | NULL |
type 4A | GDAP1 | GDAP1 | 3-4 |
type 4B1 | 4-8 | ||
type 4C | SH3TC2 | SH3TC2 | 3-4 |
type 4E | EGR2 | EGR2 | 3-4 |
type 4F | PRX | PRX | 3-4 |
type 4J | FIG4 | FIG4 | 2-4 |
type 5 | PRPS1 | PRPS1 | 3-4 |
X-chromsomal | Cx32 / GJB1 | Cx32 / GJB1 | 3-4 |
LRSAM1 | LRSAM1 | ||
SBF2 | SBF2 | NULL | |
NEFL | NEFL | 2-4 | |
CHD7 | CHD7 | 2-4 | |
Chediak-Higashi syndrome | LYST | LYST | 4-6 |
cherubism | SH3BP2 | SH3BP2 | 4-6 |
ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1, ... | ATP8B1, ABCB4, MYO5B, ABCG5, ABCG8, CYP7B1,... | 8-12 | |
Blomstrand type | PTH1R | PTH1R | NULL |
metaphyseal, Schmid type | COL10A1 | COL10A1 | 2-3 |
Chorea Huntington | HTT | HTT | 4-5 |
NULL | |||
NULL | |||
chronic granulomatosis | CYBB | CYBB | 4-6 |
chronic granulomatosis | CYBA, CYBB, NCF1, NCF2, NCF4 | CYBA, CYBB, NCF1, NCF2, NCF4 | 10-12 |
IgVH | IgVH | 2-3 | |
NGS | AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 | AIRE, CARD9, CLEC7A, IL17F, IL17RA, IL17RC, PTPN22, STAT1, TLR3, TRAF3IP2 | 4-6 |
CINCA syndrome | CIAS1 / NLRP3 | CIAS1 / NLRP3 | 3-4 |
NGS | ALX4, FIG4, MSX2, RUNX2, VAC14 | ALX4, FIG4, MSX2, RUNX2, VAC14 | 4-6 |
CUBN, MMACHC, ABCD4, LMBRD1, MMADHC, MMUT, MTR, MTRR, HCFC1, TCN2 | CUBN,MMACHC,ABCD4,LMBRD1,MMADHC,MMUT,MTR,MTRR,HCFC1, TCN2 | 4-6 | |
VPS13B/COH1 | VPS13B/COH1 | 4-6 | |
VPS13B/COH1 | VPS13B/COH1 | 2-3 | |
coloboma | PAX6 | PAX6 | 3-4 |
MSH6, EPCAM | MSH6, EPCAM | 4-6 | |
NGS | MLH1, MSH2, MSH6, PMS2, EPCAM | MLH1, MSH2, MSH6, PMS2, EPCAM | 4-8 |
type 1 / 2 | MLH1, MSH2 | MLH1, MSH2 | 4-6 |
type 2 | MLH1 | MLH1 | 4-6 |
type 4 | PMS2 | PMS2 | 4-6 |
type 5 | MSH6 | MSH6 | 4-6 |
type 7 | MLH3 | MLH3 | 4-6 |
type 8 | EPCAM | EPCAM | 4-8 |
type 8 | EPCAM | EPCAM | 3-4 |
type1 | MSH2 | MSH2 | 4-6 |
C1QTNF5 | C1QTNF5 | 3-4 | |
- | OPN1LW | OPN1LW | 3-4 |
- | AIPL1 | AIPL1 | 2-4 |
- | C21ORF2 | C21ORF2 | 3-4 |
- | CDH3 | CDH3 | 3-4 |
- | CRX | CRX | 3-4 |
- | CTNNA1 | CTNNA1 | 3-4 |
- | FBLN5 | FBLN5 | NULL |
- | GUCY2D | GUCY2D | 3-4 |
- | HMCN1 | HMCN1 | 4-8 |
- | KCNV2 | KCNV2 | 3-4 |
- | PDE6C | PDE6C | 3-4 |
- | PRPH2, BEST1 | PRPH2, BEST1 | 3-4 |
- | RAX2 | RAX2 | 3-4 |
- | PRPH2 | PRPH2 | 3-4 |
- | RGS9 | RGS9 | 3-4 |
- | RIMS1 | RIMS1 | 3-4 |
- | RPGR | RPGR | 3-4 |
- | RPGRIP1 | RPGRIP1 | 3-4 |
Type 20 | POC1B | POC1B | 2-4 |
Type 21 | DRAM2 | DRAM2 | 2-4 |
type 3 | CACNA1F | CACNA1F | 4-5 |
type 3 | ABCA4 | ABCA4 | 2-4 |
type 3 | GUCA1A | GUCA1A | 3-4 |
type 3 | SEMA4A | SEMA4A | NULL |
X-linked | ORF15, RPGR | ORF15, RPGR | 4-8 |
Jalili syndrome | CNNM4 | CNNM4 | 2-4 |
coproporphyria | CPOX | CPOX | 8-20 |
DCN | DCN | 2-4 | |
corneal dystrophy | SLC4A11 | SLC4A11 | 2-4 |
corneal dystrophy | ZEB1 | ZEB1 | 2-4 |
RAD21 | RAD21 | NULL | |
4-6 | |||
SMC3 | SMC3 | NULL | |
HRAS | HRAS | 2-4 | |
NGS | AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD | AKT1, KLLN, PIK3CA, PTEN, SEC23B, SDHB, SDHD | 4-6 |
type 1 | PTEN | PTEN | 3-4 |
type 1 | PTEN | PTEN | 2-3 |
type 1 | PTEN | PTEN | 2-3 |
type 2 | SDHB | SDHB | 3-4 |
type 3 | SDHD | SDHD | 3-4 |
type 4 | KLLN | KLLN | 3-4 |
type 5 | PIK3CA | PIK3CA | 3-4 |
type 6 | AKT1 | AKT1 | 3-4 |
type 7 | SEC23B | SEC23B | 3-4 |
NGS | ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT122, IFT43, IHH, IL11RA, IRX5, KRAS, LRP5, MASP1, MEGF8, MSX2, MYH3, P4HB, POR, RAB23, RECQL4, SCARF2, SEC24D, SKI, SMAD6, SPECC1L, STAT3, TCF12, TGFBR1.... | ALPL, ALX4, BMP4, CCBE1, CDC45, COLEC11, CYP26B1, EFNB1, ERF, ESCO2, FGFR1, FGFR2, FGFR3, GLI3, IFT1 | 4-6 |
Crouzon syndrome with acanthosis nigricans | FGFR3 | FGFR3 | 3-4 |
NGS | diverse Gene | diverse Gene | 4-8 |
ALG9 | ALG9 | 2-4 | |
cystinosis | CTNS | CTNS | 2-4 |
cystinosis | CTNS | CTNS | 2-4 |
NULL | |||
NULL | |||
Darier disease | ATP2A2 | ATP2A2 | 4-6 |
NGS | 4-6 | ||
DSPP | DSPP | NULL | |
WAC | WAC | NULL | |
Desbuquois Syndrome | CANT1 | CANT1 | 3-4 |
- | AQP2 | AQP2 | 2-4 |
- | AVPR2 | AVPR2 | 2-4 |
- | ABCC8 | ABCC8 | 2-4 |
- | EIF2AK3 | EIF2AK3 | 2-4 |
- | GCK | GCK | 2-4 |
- | INS | INS | 2-4 |
- | INS | INS | 2-4 |
- | KCNJ11 | KCNJ11 | 2-4 |
- | ZFP57, PLAGL1, KCNJ11, INS, ZC2HC1B, IGF2R, ZC2HC1B, NMBR | ZFP57,PLAGL1,KCNJ11,INS,ZC2HC1B,IGF2R,ZC2HC1B,NMBR | 2-4 |
Diamond Blackfan anemia | GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 | GATA1, TSR2, RPL5, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26 | 4-6 |
Diamond Blackfan anemia | RPS19 | RPS19 | 2-4 |
DiGeorge syndrome | TBX1 | TBX1 | 4-5 |
isolated congenital | HPGD | HPGD | 2-4 |
FLNC | FLNC | NULL | |
4-8 | |||
Donnai-Barrow syndrome | LRP2 | LRP2 | 4-6 |
Doyne honeycomb degeneration of retina | EFEMP1 | EFEMP1 | 3-4 |
Dubin Johnson syndrome | ABCC2 | ABCC2 | 4-6 |
DYM | DYM | 2-4 | |
spondylocostal | DLL3 | DLL3 | 4-6 |
spondylocostal | HES7 | HES7 | 4-6 |
spondylocostal | LFNG | LFNG | 4-6 |
spondylocostal | MESP2 | MESP2 | 4-6 |
postaxial | DHODH | DHODH | 2-4 |
acromesomelic , Maroteaux Type | NPR2 | NPR2 | 4-6 |
acromesomelic, Hunter-Thompson type | GDF5 | GDF5 | 2-4 |
campomelic | SOX9 | SOX9 | 2-4 |
campomelic | SOX9 | SOX9 | 2-3 |
cleidocrania | RUNX2 | RUNX2 | 2-3 |
cleidocranial | RUNX2 | RUNX2 | 2-4 |
dyssegmental, Silverman-Handmaker type | HSPG2 | HSPG2 | 4-6 |
familial isolated arrhythmogenic ventricular | DSG2 | DSG2 | 2-4 |
familial isolated arrhythmogenic ventricular | PKP2 | PKP2 | 2-4 |
familial isolated arrhythmogenic ventricular | PKP2 | PKP2 | 2-4 |
frontometaphyseal | MAP3K7 | MAP3K7 | 4-6 |
multiple epiphyseal, type 4 | SLC26A2 | SLC26A2 | 2-4 |
oculodentodigital | GJA1 | GJA1 | 3-4 |
odontoonychoderma | WNT10A | WNT10A | NULL |
thanatophoric | FGFR3 | FGFR3 | 3-4 |
- | HESX1 | HESX1 | 8-9 |
DSC2 | DSC2 | NULL | |
DYT25 | GNAL | GNAL | 5-6 |
VLDLR | VLDLR | NULL | |
Eagle-Barret syndrome | CHRM3 | CHRM3 | 5-6 |
hair/nail type | KRT85 | KRT85 | 4-8 |
EGFR | EGFR | 4-6 | |
COL5A1 | COL5A1 | NULL | |
- | EVC | EVC | 2-4 |
- | EVC, EVC2 | EVC, EVC2 | 2-4 |
- | EVC2 | EVC2 | 2-4 |
breast cancer | 1 | ||
congenital, due to enteropeptidase deficiency | TMPRSS15/PRSS7 | TMPRSS15/PRSS7 | 2-4 |
SLF2 | SLF2 | 2-4 | |
ACY1 | ACY1 | ||
SCN8A | SCN8A | 4-5 | |
SYNJ1 | SYNJ1 | NULL | |
- | COL7A1, KRT5 | COL7A1, KRT5 | 2-3 |
- | COL17A1 | COL17A1 | 6-8 |
dystrophica | COL7A1 | COL7A1 | 6-8 |
Herlitz type | LAMC2 | LAMC2 | 3-4 |
junctional | LAMA3 | LAMA3 | 4-5 |
junctional, Herlitz type | LAMB3 | LAMB3 | 3-4 |
junctional, non-Herlitz type | ITGB4 | ITGB4 | 2-4 |
junctional, type non-Herlitz | LAMB3 | LAMB3 | 3-4 |
NGS | COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 | COL7A1, ITGB4, LAMA3, LAMB3, LAMC2, KRT14, KRT5 | 4-8 |
simplex | KRT14 | KRT14 | 3-4 |
simplex | KRT5 | KRT5 | 3-4 |
epidermolytic palmoplantar keratoderma | KRT1 | KRT1 | 4-8 |
epidermolytic palmoplantar keratoderma | KRT9 | KRT9 | 4-8 |
PCDH19 | PCDH19 | NULL | |
HCN1 | HCN1 | ||
NTRK2 | NTRK2 | 4-6 | |
SLC6A1 | SLC6A1 | NULL | |
CACNA1E | CACNA1E | NULL | |
- | EPOR | EPOR | 4-6 |
- | EPOR | EPOR | 4-6 |
- | EPOR | EPOR | 2-4 |
6 | |||
type 1 | FZD4 | FZD4 | 2-4 |
type 4 | LRP5 | LRP5 | 3-4 |
Fabry disease | GLA | GLA | 3-4 |
Fabry disease | GLA | GLA | 2-3 |
factor 10 deficiency | F10 | F10 | 2-3 |
factor 13A1 deficiency | F13A1 | F13A1 | 4-6 |
factor 7 deficiency | F7 | F7 | 4-6 |
familial cerebral cavernous malformation | PDCD10 | PDCD10 | 4-5 |
type 3 | CLDN16 | CLDN16 | 2-4 |
type 5 | CLDN19 | CLDN19 | 2-4 |
- | BRIP1/FANCJ | BRIP1/FANCJ | 4-8 |
- | FANCA | FANCA | 4-8 |
- | FANCA | FANCA | 3-4 |
- | FANCC | FANCC | 4-8 |
- | FANCD1/BRCA2 | FANCD1/BRCA2 | 4-8 |
- | FANCI | FANCI | 4-8 |
hromosomal breakage study | 2-3 | ||
NGS | BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 | BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, PALB2, SLX4, XRCC2 | 4-8 |
FANCA | FANCA | ||
ASAH1 | ASAH1 | 2-4 | |
NGS | AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EIF2B4, EIF2B5, EIF4ENIF1, ESR1, ESR2, F2, F5, FIGLA, FGF8, FGFR1, FOXL2, FSHB, FSHR, GNRH1, GNRHR, HARS2, HFM1, HSD17B3, HSD17B4, INHA, KHDC3L, KISS1, .... | AR, BMP15, BTG4, BUB1B, CBX2, C11orf80, CFTR, CLPP, CPEB1, CYP21A2, CYP11A1, DHH, EIF2B1, EIF2B2, EI | 4-6 |
FGFR2 | FGFR2 | 4-5 | |
Floating-Harbor syndrome | SRCAP | SRCAP | 4-5 |
4-8 | |||
FMR1 | FMR1 | 2-5 | |
Fragile X syndrome | FMR1 | FMR1 | 4-5 |
Frank-Ter Haar syndrome | SH3PXD2B | SH3PXD2B | 6-8 |
Friedreich ataxia | FXN | FXN | 3-4 |
Friedreich ataxia | FXN | FXN | 2-4 |
fructose intolerance | ALDOB | ALDOB | 2-4 |
SMCHD1 | SMCHD1 | ||
1-2 | |||
galactokinase deficiency with cataracts | GALK1 | GALK1 | 2-4 |
- | CTNNA1 | CTNNA1 | 4-8 |
NGS | APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 | APC, CDH1, CTNNA1, DOT1L, FBXO24, INSR, MAP3K6, TP53 | 4-8 |
GBA | GBA | 2-3 | |
ACTL6A | ACTL6A | 2-4 | |
SOX3 | SOX3 | 2-4 | |
type 1 | ENPP1 | ENPP1 | 2-4 |
generalized pustular psoriasis | IL36RN | IL36RN | 3-4 |
NULL | |||
NULL | |||
6-10 | |||
juvenile type | CTSA | CTSA | 2-4 |
Gilbert syndrome | UGT1A1 | UGT1A1 | 1-2 |
4-6 | |||
BVES | BVES | NULL | |
glioma | POT1 | POT1 | 2-4 |
glioma | POT1 | POT1 | 2-4 |
NGS | TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 | TP53, BRCA2, POT1, PTEN, MSH2, MSH6, MLH1, PMS2, CDKN2A, CDKN2B, RTEL1, TSC1, NF1, NF2 | 4-8 |
glomuvenous malformation | GLMN | GLMN | NULL |
NGS | AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 | AAAS, AIRE, CYP11A1, MC1R, MC2R, MCM4, MRAP, NNT, NR0B1 (DAX1), NR3C1, POMC, STAR, TBX19, TXNRD2 | 4-6 |
glucose/galactose malabsorption | SLC5A1 | SLC5A1 | 2-4 |
type I | GCDH | GCDH | 8-12 |
glycine amidinotransferase deficiency | GATM | GATM | 5-7 |
glycine encephalopathy | AMT | AMT | 3-4 |
glycine encephalopathy | GLDC | GLDC | 3-4 |
RFT1 | RFT1 | 3-6 | |
congenital | PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, SRD5A3, DDOST, ALG13, PGM1, DPM2, STT3A, STT3B, SSR4, ATP6V0A2, MAGT1, TUSC3, DHDDS, GMPPA, PGM3, NUS1 | PMM2, MPI, ALG6, ALG3, DPM1, MPDU1, ALG12, ALG8, ALG2, DPAGT1, ALG1, ALG9, DOLK, RFT1, DPM3, ALG11, | 4-8 |
congenital | B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, SLC39A8, ST3GAL3, TMEM165, TMEM199 | B4GALT1, CCDC115, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MAN1B1, MGAT2, MOGS, SLC35A1, SLC35A2, S | 4-8 |
congenital | MGAT2 | MGAT2 | 4-8 |
congenital | ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, PMM2, RFT1, SRD5A3, TUSC3, B4GALT1, COG1, COG2, COG4, COG5, COG6, COG7, COG8, MGAT2, MOGS, SLC35A1, SLC35A2, SLC35C1, TMEM165 | ALG1, ALG11, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, DOLK, DPAGT1, DPM1, MAGT1, MPDU1, MPI, PGM1, PGM3, | 4-8 |
congenital type 1T | PGM1 | PGM1 | 2-4 |
congenital, type 1A | PMM2 | PMM2 | 4-8 |
congenital, type 1B | MPI | MPI | 2-4 |
congenital, type 2 | ALG9 | ALG9 | 2-4 |
type 1-3 | GLB1 | GLB1 | 14-16 |
Goltz-Gorlin syndrome | PORCN | PORCN | 4-5 |
SUFU | SUFU | ||
GLI3 | GLI3 | 2-3 | |
gyrate atrophy of the choroid and retina | OAT | OAT | 2-4 |
SLC29A3 | SLC29A3 | 2-4 | |
- | BRAF | BRAF | 2 |
NGS | BRAF, KLF2, CDKN1B | BRAF, KLF2, CDKN1B | 2 |
NULL | |||
MLPA | 2-4 | ||
NGS | HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 | HFE, HFE2/HJV, HAMP, TFR2, SLC40A1, FTL, FTH1 und BMP6 | 4-8 |
type 1 | HFE | HFE | 4-8 |
type 2A | HFE2/HJV | HFE2/HJV | 4-8 |
NGS | 4-6 | ||
hemophilia A | F8 | F8 | 2-3 |
hemophilia A | F8 | F8 | 4-5 |
prognostic marker | ITPA | ITPA | NULL |
type 1 | SLC22A12 | SLC22A12 | 2-4 |
type 2 | SLC2A9 | SLC2A9 | 2-4 |
APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR | APOA1, APOA2, APP, B2M, CST3, FGA, GSN, ITM2B, LYZ, PRNP, TTR | 4-6 | |
GGCX | GGCX | 2-4 | |
3-5 | |||
ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC | ADAMTS3, CCBE1, CELSR1, EPHB4, FAT4, FLT4, FOXC2, GJC2, KIF11, PIEZO1, PTPN14, SOX18, VEGFC | 4-6 Wochen | |
verschiedene Gene für HPS | verschiedene Gene für HPS | 4-8 | |
type 5 | HPS5 | HPS5 | 2-4 |
type 6 | HPS6 | HPS6 | 2-4 |
type 8 | BLOC1S3 | BLOC1S3 | 2-4 |
type 1 | HPS1 | HPS1 | 2-4 |
ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP52, CFAP53, CFC1, CRELD1, DNAAF1, DNAAF2, DNAAF3, DNAAF4, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, DNAJB13, DNAL1, DRC1, FOXH1, GALNT11, GAS2L2, GAS8, GDF1, HYD | ACVR2B, ANKS3, ARMC4, BCL9L, CCDC103, CCDC114, CCDC151, CCDC39, CCDC40, CCDC65, CCNO, CFAP298, CFAP5 | 4-8 | |
EDN3 | EDN3 | 3-4 | |
- | EDNRB | EDNRB | 3-4 |
verschiedene Gene | verschiedene Gene | NULL | |
susceptibility/resistance to | CCR5 | CCR5 | 2-3 |
NGS | diverse Gene | diverse Gene | 4-8 |
NGS | DICER, FAS, POT1, PTPN11, TP53 | DICER, FAS, POT1, PTPN11, TP53 | 4-6 |
Hutchinson-Gilford progeria | LMNA | LMNA | 3-4 |
KYNU | KYNU | 5-6 | |
L1CAM | L1CAM | 3-4 | |
Hyper-IgD-Syndrom | MVK | MVK | |
SCN4A | SCN4A | 3-5 | |
NGS | APOB, CETP, LDLR, LDLRAP1, LIPA, PCSK9, STAP1 | APOB,CETP,LDLR,LDLRAP1,LIPA,PCSK9,STAP1 | 4-6 |
1 | GLRA1 | GLRA1 | 8-20 |
1-3 | GLRA1, GLRB, SLC6A5 | GLRA1, GLRB, SLC6A5 | 4-6 |
2 | GLRB | GLRB | 8-20 |
3 | SLC6A5 | SLC6A5 | 8-12 |
hyperferritinemia | FTL | FTL | 4-6 |
hyperferritinemia | FTL | FTL | 4-6 |
UCP2 | UCP2 | 2-4 | |
type 3 | APOE | APOE | 2-3 |
hyperlipoproteinemia | LPL | LPL | 2-4 |
hyperostosis corticalis generalisata | LRP5 | LRP5 | 3-4 |
SLC26A1 | SLC26A1 | 2-4 | |
type 3 | HOGA1/DHDPSL | HOGA1/DHDPSL | 2-4 |
4-6 | |||
2-4 Wochen | |||
TRPV6 | TRPV6 | 2-4 | |
PIGV | PIGV | NULL | |
PIGW | PIGW | NULL | |
type 2 | ALDH4A1 | ALDH4A1 | 3-4 |
malignant | RYR1, CACNA1S, STAC3 | RYR1, CACNA1S,STAC3 | 4-6 |
4-6 | |||
Hypoalphalipoproteinemia | LCAT | LCAT | 2-4 |
Hypocalcemia | CASR | CASR | 2-4 |
Hypocalcemia | CASR | CASR | 2-4 |
COL2A1 | COL2A1 | 2-3 | |
hypochondrogenesis | COL2A1 | COL2A1 | 4-6 |
hypochondrogenesis | COL2A1 | COL2A1 | 4-6 |
hypochondroplasia | FGFR3 | FGFR3 | 1-2 |
hypochondroplasia | FGFR3 | FGFR3 | 3-4 |
NGS | 4-6 | ||
hypomyelinating leukodystrophy-5 | FAM126A | FAM126A | 4-6 |
hypophosphatasia | ALPL/TNSALP | ALPL/TNSALP | 4-6 |
hypophosphatasia | ALPL/TNSALP | ALPL/TNSALP | 2 |
hypophosphatasia | ALPL/TNSALP | ALPL/TNSALP | 4-6 |
SLC9A3R1 | SLC9A3R1 | 2-4 | |
4-6 | |||
autosomal dominant | FGF23 | FGF23 | 2-4 |
autosomal dominant | FGF23 | FGF23 | 2-4 |
X-linked dominant | PHEX | PHEX | 2-4 |
X-linked dominant | PHEX | PHEX | 2-4 |
hypoplastic left heart syndrome | NKX2-5 | NKX2-5 | 2-4 |
IGF1 deficiency | IGF1 | IGF1 | 2-4 |
IGF1 deficiency | IGF1 | IGF1 | 2-4 |
IL3RA | IL3RA | 2-4 | |
immuno deficiency | IRAK4 | IRAK4 | 6-8 |
immuno deficiency 47 | ATP6AP1 | ATP6AP1 | 4-8 |
immunoglobulin A (IgA) deficiency | TNFRSF13B | TNFRSF13B | 4-6 |
Infantile Hypercalciuria | CYP24A1 | CYP24A1 | 2-4 |
infertility, CBAVD | CFTR | CFTR | 3-4 |
infertility, CBAVD | CFTR | CFTR | 3-4 |
HIVEP2 | HIVEP2 | NULL | |
MBOAT7 | MBOAT7 | ||
CNKSR2 | CNKSR2 | NULL | |
USP9X | USP9X | NULL | |
GRIA3 | GRIA3 | NULL | |
SETD5 | SETD5 | NULL | |
TRAPPC11 | TRAPPC11 | ||
Interleukin-1 receptor antagonist deficiency | IL1RN | IL1RN | 3-5 |
IPEX syndrome | FOXP3 | FOXP3 | 2-4 |
Irinotecan Therapy | UGT1A1 | UGT1A1 | 2-3 |
isovaleric acidemia | IVD | IVD | 5-6 |
Jackson-Weiss syndrome | FGFR2 | FGFR2 | 1-2 |
Jackson-Weiss syndrome | FGFR2 | FGFR2 | 3-4 |
JPM syndrome | PSMB8 | PSMB8 | 8-12 |
CACNB4 | CACNB4 | 34-35 | |
CACNG4 | CACNG4 | NULL | |
LDB3 | LDB3 | NULL | |
PLN | PLN | NULL | |
SLC25A3 | SLC25A3 | 3-4 | |
CAV3 | CAV3 | 2-4 | |
LMNA | LMNA | 2-4 | |
TTN | TTN | NULL | |
3-Hydroxyisobutyrate dehydrogenase deficiency | HIBADH | HIBADH | 2-4 |
MGP | MGP | 4-6 | |
1-2 | |||
KMT2C | KMT2C | NULL | |
type 1 | GDF6 | GDF6 | 8-20 |
type 3 | GDF3 | GDF3 | 8-20 |
Klippel-Feil syndrome 2 | MEOX1 | MEOX1 | 8-20 |
type 1 | COL18A1 | COL18A1 | 2-4 |
CARS2 | CARS2 | ||
ITPR3 | ITPR3 | ||
TUBB | TUBB | 2-4 | |
Krabbe disease | GALC | GALC | 6-10 |
L-2-hydroxyglutaric aciduria | L2HGDH | L2HGDH | 8-10 |
congenital | LCT | LCT | 3-4 |
LARGE associated diseases | LARGE | LARGE | 5-6 |
Laron syndrome | GHR | GHR | 2-4 |
Laron syndrome | GHR, IGF1, JAK2, STAT5B | GHR, IGF1, JAK2, STAT5B | 2-4 |
Larsen syndrome | FLNB | FLNB | 2-3 |
Larsen syndrome | FLNB | FLNB | 3-4 |
Larsen syndrome | FLNB | FLNB | 5-6 |
NGS | FLNB | FLNB | 3-4 |
amyotrophic | KIF5A | KIF5A | 3-4 |
amyotrophic | SOD1 | SOD1 | 3-4 |
amyotrophic 14 | VCP | VCP | 2-6 |
Type 2 | ALS2 | ALS2 | 1-9 / 100 000 |
BRPF1 | BRPF1 | NULL | |
GABRB3 | GABRB3 | 2-4 | |
Leopard syndrome | PTPN11 | PTPN11 | 3-4 |
- | CEBPA | CEBPA | 2 |
- | CALM-AF10 | CALM-AF10 | 2 |
- | CBFB-MYH11 | CBFB-MYH11 | 2 |
- | DEK-CAN | DEK-CAN | 2 |
- | CBL | CBL | 2 |
- | FLT3 | FLT3 | 2 |
- | IDH1 | IDH1 | 2 |
- | IDH2 | IDH2 | 2 |
- | KIT | KIT | 2 |
- | KMT2A-ELL | KMT2A-ELL | 2 |
- | KMT2A-MLLT1 | KMT2A-MLLT1 | 2 |
- | KMT2A-MLLT3 | KMT2A-MLLT3 | 2 |
- | KMT2A-MLLT4 | KMT2A-MLLT4 | 2 |
- | KRAS | KRAS | 2 |
- | MLL-PTD/KMT2A-PTD | MLL-PTD/KMT2A-PTD | 2 |
- | NPM1 | NPM1 | 2 |
- | NPM1 | NPM1 | 2 |
- | NPM1-MLF1 | NPM1-MLF1 | 2 |
- | RUNX1 | RUNX1 | 2 |
- | TET2 | TET2 | 2 |
- | WT1 | WT1 | 2 |
- | RUNX1-RUNX1T1 | RUNX1-RUNX1T1 | 2 |
NGS | ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP53 , WT1 | ASXL1, BCOR, CEBPA, DNMT3A, FLT3, GATA2, IDH1, IDH2, KRAS, KIT, NPM1, NRAS, PTPN11, RUNX1, TET2, TP | 2 |
- | FLT3-ITD | FLT3-ITD | 2-3 |
qualitative | PML-RARA | PML-RARA | 1 |
quantitative | PML-RARA | PML-RARA | 1-2 |
NGS | ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 | ASXL1, CALR, CBL, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NRAS, RUNX1, SETBP1, | 2 |
NGS | CSF3R, SETBP1, ASXL1 | CSF3R, SETBP1, ASXL1 | 2 |
NGS | CBL, NRAS, KRAS, PTPN11 | CBL, NRAS, KRAS, PTPN11 | 2 |
- | DNMT3A | DNMT3A | 2 |
- | NRAS | NRAS | 2 |
NGS | JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 | JAK2, JAK1, CRLF2, KRAS, NRAS, PTPN11, IKZF1, ASXL1, ARID2, CHD2, TP53 | 2 |
ITGB2, SLC35C1, FERMT3 | ITGB2, SLC35C1, FERMT3 | 4-6 | |
Type 1 | ITGB2 | ITGB2 | 2-4 |
Type 3 | FERMT3 | FERMT3 | 2-4 |
NGS | LEUK | LEUK | |
quantitative | BCR-ABL1 p190/e1a2 | BCR-ABL1 p190/e1a2 | 1-2 |
CEBPA, FLT3-ITD, cKIT, NPM1 | CEBPA, FLT3-ITD, cKIT, NPM1 | NULL | |
Li-Fraumeni syndrome | TP53 | TP53 | 2-4 |
Li-Fraumeni syndrome | TP53 | TP53 | 4-6 |
NGS | ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, FBLN1, FGF10, FGF16, FGF9, FGFR1, FGFR2, FGFR3, FMN1, GDF5, GDF6, GJA1, GLI3, GNAS, GREM1, GSC, HDAC4, HDAC8, HOXA11, HOXA13, HOXD13, IHH, KCNJ2, KIF7, ... | ARHGAP31, BHLHA9, BMP2, BMPR1B, CDH3, CHSY1, CKAP2L, DHODH, DLL4, DLX5, DOCK6, EOGT, ESCO2, FAM58A, | 4-6 |
FKTN | FKTN | 2-4 | |
linear skin defects with multiple congenital anoma | COX7B | COX7B | 3-4 |
linear skin defects with multiple congenital anoma | HCCS | HCCS | 3-4 |
- | PPARG | PPARG | 2-4 |
- | LMNB2 | LMNB2 | 2-4 |
type 1 | LIS1/PAFAH1B1 | LIS1/PAFAH1B1 | 4-5 |
type 2 | RELN | RELN | 8-12 |
X-linked | DCX | DCX | 8-9 |
TUBA1A | TUBA1A | NULL | |
SCN5A | SCN5A | NULL | |
CALM2 | CALM2 | NULL | |
LQT1 | KCNQ1 | KCNQ1 | 2-4 |
LQT1, LQT2, LQT5, LQT6 | KCNQ1, KCNH2, KCNE1, KCNE2 | KCNQ1, KCNH2, KCNE1, KCNE2 | 2-4 |
LQT10 | SCN4B | SCN4B | 2-4 |
LQT2 | KCNH2 | KCNH2 | 2-4 |
LQT5 | KCNE1 | KCNE1 | 2-4 |
LQT6 | KCNE2 | KCNE2 | 2-4 |
LQT7 | KCNJ2 | KCNJ2 | 2-4 |
NGS | CALM1, CALM2, AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1, TRPM4 | CALM1,CALM2,AKAP9,ANK2,CACNA1C,CAV3,KCNE1,KCNE2,KCNH2,KCNJ2,KCNJ5,KCNQ1,SCN4B,SCN5A,SNTA1,TRPM4 | 4-6 |
type 3 | SCN5A | SCN5A | 2-4 |
long-chain 3-hydroxyl-CoA dehydrogenase deficiency | HADHA | HADHA | 4-8 |
CACNA1C | CACNA1C | ||
Lowe syndrome | OCRL/OCRL1 | OCRL/OCRL1 | 2-4 |
hemophagocytic | PRF1, STX11, UNC13D | PRF1,STX11, UNC13D | 2-4 |
hemophagocytic, type 2 | PRF1 | PRF1 | 4-8 |
hemophagocytic, type 3 | UNC13D | UNC13D | 4-8 |
hemophagocytic, type 4 | STX11 | STX11 | 4-8 |
hemophagocytic, type 5 | STXBP2 | STXBP2 | 4-8 |
NGS | PRF1, UNC13D, STX11, STXBP2 | PRF1, UNC13D, STX11, STXBP2 | 4-8 |
NGS | PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 | PLCG1, TP53, TET2, CREBBP, KMT2D/MLL2 | 2 |
X-linked | XIAP | XIAP | 3-4 |
PDE11A | PDE11A | 2-4 | |
- | MPDZ | MPDZ | 2-4 |
CDH1 | CDH1 | ||
4-8 | |||
NULL | |||
NGS | AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, CFAP70, CFTR, CYP11B1, CYP17A1, CYP21A2, DMRT1, DNAH1, DNAH2, DNAH5, DNAH6, DNAH8, DNAH9, DNAH17, DNAJB13, DPY19L2, FANCM, FGF8, FGFR1, FSIP2, FSHB, ..... | AMH, AMHR2, ANOS1, AR, ARMC2, AURKC, BNC2, CATSPER1, CCDC39, CFAP43, CFAP44, CFAP47, CFAP65, CFAP69, | 4-6 |
KCNT1 | KCNT1 | NULL | |
MLYCD | MLYCD | 2-4 | |
NGS | BCKDHA, BCKDHB, DBT, DLD | BCKDHA, BCKDHB, DBT, DLD | 4-6 |
type 1A | BCKDHA | BCKDHA | 2-4 |
type 1B | BCKDHB | BCKDHB | 2-4 |
type 2 | DBT | DBT | 2-4 |
Marden-Walker syndrome | PIEZO2 | PIEZO2 | 8-12 |
Marfan syndrome | FBN1 | FBN1 | 2-4 |
Marfan syndrome | FBN1 | FBN1 | 2-4 |
NGS | FBN1, TGFBR1, TGFBR2 | FBN1,TGFBR1,TGFBR2 | 4-6 |
NGS | BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 | BIRC3, CARD11, KLF2, KMT2D, MYD88, NOTCH1, NOTCH2, TNFAIP3, TRAF3, TP53 | 2 |
NGS | ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 | ASXL1, CBL, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, NRAS, RUNX1, SRSF2, TET2, U2AF1 | 2 |
GNAS | GNAS | 4-6 | |
Medium-chain acyl-CoA dehydrogenase deficiency | ACADM | ACADM | 2-4 |
Medium-chain acyl-CoA dehydrogenase deficiency | ACADM | ACADM | 2-4 |
AKT3 | AKT3 | NULL | |
Meier-Gorlin syndrome 1 | ORC1 | ORC1 | 7-8 |
MELAS syndrome | MT-TL1 | MT-TL1 | 2-4 |
Menke disease | ATP7A | ATP7A | 3-4 |
CLTC | CLTC | ||
DLG4 | DLG4 | ||
MERRF syndrome | MTTK | MTTK | 2-4 |
metachromatic leucodystrophy | ARSA | ARSA | 4-6 |
1-2 | |||
type 1 and 2 | CYB5R3 | CYB5R3 | 2-4 |
type 1 and 2 | CYB5R3 | CYB5R3 | 4-8 |
cblC | MMACHC | MMACHC | 2-4 |
cblC | MMACHC | MMACHC | 2-4 |
cblD | MMADHC | MMADHC | 2-4 |
methylmalonyl-CoA mutase deficiency | MMUT | MMUT | 6-8 |
sequence analysis MMUT | MMUT | MMUT | 2-4 |
NSUN2 | NSUN2 | 6-10 | |
SLC25A22 | SLC25A22 | 2-4 | |
SUOX | SUOX | 3-5 | |
LIG4 | LIG4 | 4-6 | |
4-8 | |||
- | CEP63 | CEP63 | 3-5 |
- | IER3IP1 | IER3IP1 | 3-5 |
- | KIF11 | KIF11 | 3-5 |
- | MYO16 | MYO16 | 3-5 |
- | PCNT | PCNT | 3-5 |
- | RBBP8 | RBBP8 | 4-6 |
- | RTTN | RTTN | 3-5 |
- | SLC25A19 | SLC25A19 | 3-5 |
- | TRAPPC9 | TRAPPC9 | 3-5 |
- | TUBB2B | TUBB2B | 3-5 |
MCPH1 | MCPH1 | MCPH1 | 3-5 |
MCPH2 | WDR62 | WDR62 | 3-5 |
MCPH3 | CDK5RAP2 | CDK5RAP2 | 3-5 |
MCPH4 | CASC5 | CASC5 | 3-5 |
MCPH4, MCPH9 | CEP152 | CEP152 | 3-5 |
MCPH5 | ASPM | ASPM | 3-5 |
MCPH6 | CENPJ | CENPJ | 3-5 |
MCPH8 | CEP135 | CEP135 | 5-7 |
Seckel syndrome | ATR | ATR | 3-5 |
- | PLK4 | PLK4 | 2-4 |
microvillus inclusion disease | MYO5B | MYO5B | 9-10 |
familial hemiplegic | ATP1A2, CACNA1A, NOTCH3, SCN1A | ATP1A2, CACNA1A, NOTCH3, SCN1A | 4-8 |
familial hemiplegic 2 | ATP1A2 | ATP1A2 | 8-10 |
familial hemiplegic 3 | SCN1A | SCN1A | 4-5 |
familial hemiplegic type 1 | CACNA1A | CACNA1A | 4-6 |
4-8 | |||
STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 | STIL, ASPM, MCPH1, CDK5RAP2, CENPJ, WDR62 | 2-4 | |
QARS | QARS | NULL | |
NGS | MLH1, MSH2, MSH6, PMS2 | MLH1, MSH2, MSH6, PMS2 | 4-8 |
MITF | MITF | 3-4 | |
NGS | MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH, MT-TI, MT-TK, MT-TL1, MT-TL2, MT-TM, MT-TN, MT-TP, MT-TQ, MT-TR, MT-TS1, MT-TS2, MT-TT, MT-TV, MT-TW, MT-TY | MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MT-RNR | 4-6 |
MNGIE syndrome | TYMP, POLG, MGME1, RRM2B | TYMP, POLG, MGME1, RRM2B | 4-6 |
MNGIE syndrome | TYMP | TYMP | 2-4 |
MLPA | HNF1A, GCK, HNF4A und HNF1ß | HNF1A, GCK, HNF4A und HNF1ß | 2-4 |
MLPA | PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS | PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS | 2-4 |
NGS | HNF4A, HNF1A, HNF1B, GCK, IPF1/PDX1, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 | HNF4A,HNF1A,HNF1B,GCK,IPF1/PDX1,NEUROD1,KLF11,CEL,PAX4,INS,BLK,ABCC8,KCNJ11,APPL1 | 4-6 |
type 1 | HNF4A | HNF4A | 2-4 |
type 11 | BLK | BLK | 2-4 |
type 14 | APPL1 | APPL1 | 2-4 |
type 2 | GCK | GCK | 2-4 |
type 3 | HNF1A | HNF1A | 2-4 |
type 4 | IPF1/PDX1 | IPF1/PDX1 | 2-4 |
type 5 | HNF1B | HNF1B | 2-4 |
type 6 | NEUROD1 | NEUROD1 | 4-6 |
type 7 | KLF11 | KLF11 | 2-4 |
type 8 | CEL | CEL | 2-4 |
type 9 | PAX4 | PAX4 | 2-4 |
4-8 | |||
type A | MOCS1 | MOCS1 | 9-10 |
type B | MOCS2 | MOCS2 | 9-10 |
type C | GPHN | GPHN | 4-8 |
NGS | AGPAT2, AKT2, BSCL2, CAV1, CIDEC, FBN1, INSR, LMNA, LMNB2, PPARG, PTRF, ZMPSTE24, POLD1 | AGPAT2,AKT2,BSCL2,CAV1,CIDEC,FBN1,INSR,LMNA,LMNB2,PPARG,PTRF,ZMPSTE24,POLD1 | 4-8 |
- | CXCR4 | CXCR4 | 2 |
- | MYD88 | MYD88 | 2 |
NGS | MYD88, CXCR4, ARID1A, KMT2D (MLL2) | MYD88, CXCR4, ARID1A, KMT2D (MLL2) | 2 |
mosaic variegated aneuploidy syndrome 1 | BUB1B | BUB1B | 4-6 |
Mowat-Wilson syndrome | ZEB2/ZFHX1B | ZEB2/ZFHX1B | 5-6 |
NGS | ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH | ARSB, GALNS, GLB1, GNS, GUSB, HGSNAT, HYAL1, IDS, IDUA, NAGLU, SGSH | 4-6 |
type 1H | IDUA | IDUA | 4-6 |
type 3A | SGSH | SGSH | 2-4 |
type 3B | NAGLU | NAGLU | 2-4 |
type 3C | HGSNAT | HGSNAT | 2-4 |
type 4A | GALNS | GALNS | 2-4 |
type 4B | GLB1 | GLB1 | 2-4 |
type 6 | ARSB | ARSB | 2-4 |
type 7 | GUSB | GUSB | 2-4 |
Muenke syndrome | FGFR3 | FGFR3 | 1-2 |
CFTR | CFTR | 2-4 | |
PLAGL1, GRB10, MEST, H19, KCNQ1OT1, DLK1, MEG3, RTL1, SNRPN, PEG3, GNAS | PLAGL1,GRB10,MEST,H19,KCNQ1OT1,DLK1,MEG3,RTL1,SNRPN,PEG3,GNAS | 2-4 | |
muscle eye brain syndrome | POMGNT1 | POMGNT1 | 5-6 |
DYSF | DYSF | 2 | |
congenital | LAMA2 | LAMA2 | 8-10 |
Duchenne / Becker | DMD | DMD | 2-4 |
Duchenne / Becker | DMD | DMD | 2-4 |
Duchenne / Becker | DMD | DMD | 4-6 |
Duchenne / Becker | DMD | DMD | 2-4 |
RAPSN | RAPSN | NULL | |
SLC5A7 | SLC5A7 | NULL | |
MYH9-related disorders | MYH9 | MYH9 | 2-4 |
myoclonus-dystonia syndrome | SGCE | SGCE | 6-8 |
genetic recurrent | LPIN1 | LPIN1 | 2-4 |
CLCN2 | CLCN2 | NULL | |
SEPN1 | SEPN1 | 3-4 | |
distal | ACTA1, ANO5, CAV3, CRYAB, DES, DYSF, FHL1, FLNC, GNE, KLHL9, LDB3, MATR3, MYH14, MYH7, MYOT, NEB, RYR1, TCAP, TIA1, TPM3, VCP | ACTA1,ANO5,CAV3,CRYAB,DES,DYSF,FHL1,FLNC,GNE,KLHL9,LDB3,MATR3,MYH14,MYH7,MYOT,NEB,RYR1,TCAP,TIA1,TPM | 4-8 |
metabolic | AGL, CPT2, ETFA, ETFB, ETFDH, GAA, GBE1, LPIN1, PFKM, PYGM, RRM2B, SLC22A5 und weitere | AGL,CPT2,ETFA,ETFB,ETFDH,GAA,GBE1,LPIN1,PFKM,PYGM,RRM2B,SLC22A5 und weitere | 4-8 |
NGS | verschiedene Gene für MYOP | verschiedene Gene für MYOP | 4-8 |
Becker, Thomsen | CLCN1 | CLCN1 | 2-4 |
Becker, Thomsen | CLCN1 | CLCN1 | 2-4 |
MYT1L | MYT1L | NULL | |
N-acetylglutamate synthetase deficiency | NAGS | NAGS | 2-4 |
DCHS2 | DCHS2 | NULL | |
HGFAC | HGFAC | NULL | |
KRTAP5-4 | KRTAP5-4 | NULL | |
NRK | NRK | NULL | |
PDE4C | PDE4C | NULL | |
PLXNB1 | PLXNB1 | NULL | |
PRDM9 | PRDM9 | NULL | |
SLC5A8 | SLC5A8 | NULL | |
STAG2 | STAG2 | NULL | |
SUSD4 | SUSD4 | NULL | |
ZNFX1 | ZNFX1 | NULL | |
NQO1 | NQO1 | 2-3 | |
nail dysplasia, congenital | FZD6 | FZD6 | 3-4 |
Nail-Patella syndrome | LMX1B | LMX1B | 3-4 |
Nail-Patella syndrome | LMX1B | LMX1B | 2-3 |
- | KLHL41 | KLHL41 | 4-6 |
Amish type | TNNT1 | TNNT1 | 4-5 |
MEN2A | RET | RET | 3-4 |
NGS | RET, MEN1, CDKN1B | RET, MEN1, CDKN1B | 4-8 |
type 1 | MEN1 | MEN1 | 3-4 |
type 1 | MEN1 | MEN1 | 3-4 |
type 1 | MEN1 | MEN1 | 3-4 |
type 4 | CDKN1B | CDKN1B | 3-4 |
MEN2B | RET | RET | 3-4 |
NGS | 4-8 | ||
- | OSGEP | OSGEP | 2-4 |
- | MAGI2 | MAGI2 | 2-4 |
- | MAGI2 | MAGI2 | 2-4 |
NPHS1 | NPHS1 | NPHS1 | 2-4 |
NPHS2 | NPHS2 | NPHS2 | 2-4 |
NPHS4 | WT1 | WT1 | 1-2 |
NGS | ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 | ALK, BARD1, BLM, CHEK2, FANCD2, GALNT14, KIF1B, NKAIN2, NME1, PALB2, PHOX2B/PMX2B, PINK1, TP53 | 4-8 |
neuromyotonia and axonal neuropathy | HINT1 | HINT1 | 6-8 |
neuronal ceroid lipofuscinosis | ATP13A2 | ATP13A2 | 5-6 |
ATL3 | ATL3 | NULL | |
autosomal recessive | OTOF | OTOF | 4-6 |
NGS | ELANE, G6PC3, HAX1, JAGN1, WAS | ELANE, G6PC3, HAX1, JAGN1, WAS | 4-8 |
severe congenital 1 | ELANE/ELA2 | ELANE/ELA2 | 2-4 |
severe congenital 3 | HAX1 | HAX1 | 4-6 |
severe congenital 4 | G6PC3 | G6PC3 | 4-8 |
severe congenital 6 | JAGN1 | JAGN1 | 4-8 |
somatic mutations | CSF3R, TP53 | CSF3R, TP53 | 2 |
X-linked | WAS | WAS | 4-8 |
NFE2L3 | NFE2L3 | NULL | |
1-2 | |||
type C2 | NPC2 | NPC2 | 4-6 |
type C2 | NPC2 | NPC2 | 4-6 |
NGS | 4-6 Wochen | ||
Nijmegen breakage syndrome | NBN | NBN | 4-5 |
Nijmegen breakage syndrome | NBN | NBN | 4-5 |
PNPLA3 | PNPLA3 | 1-2 | |
non-ketotic hyperglycinemia | GCSH | GCSH | 3-4 |
GNE | GNE | NULL | |
- | BRAF | BRAF | 3-4 |
- | LZTR1 | LZTR1 | 2-4 |
- | PTPN11 | PTPN11 | 3-4 |
- | RAF1 | RAF1 | 3-4 |
- | RIT1 | RIT1 | 2-4 |
- | SOS1 | SOS1 | 3-4 |
- | CBL | CBL | 2-4 |
- | A2ML1 | A2ML1 | 2-4 |
- | SHOC2 | SHOC2 | 3-4 |
9 | SOS2 | SOS2 | 3-4 |
NGS | PTPN11, SOS1, RAF1, KRAS, BRAF, RIT1 und weitere Gene für Noonan-Syndrom | PTPN11,SOS1,RAF1,KRAS,BRAF,RIT1 und weitere Gene für Noonan-Syndrom | 4-8 |
NGS | diverse Gene | diverse Gene | 4-8 |
verschiedene Gene für NYS | verschiedene Gene für NYS | 4-8 | |
type 1 | FRMD7 | FRMD7 | 2-4 |
type 1 | FRMD7 | FRMD7 | 2-4 |
type 6 | GPR143 | GPR143 | 2-4 |
CHRNA4 | CHRNA4 | NULL | |
LRIG2 | LRIG2 | NULL | |
oculopharyngeal muscular dystrophy | PABPN1 | PABPN1 | 6-8 |
MID1 | MID1 | NULL | |
ornithine transcarbamylase deficiency | OTC | OTC | 5-8 |
ornithine transcarbamylase deficiency | OTC | OTC | 3-4 |
4-8 | |||
NULL | |||
osteopathia striata with cranial sclerosis | AMER1/WTX | AMER1/WTX | 2-3 |
type 2, 4 | CLCN7 | CLCN7 | 5-6 |
LRP5 | LRP5 | 3-4 | |
NGS | APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN | APC, BLM, MSH2, PALB2, RB1, RECQL4, TP53, WRN | 4-8 |
NGS | AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 | AAGAB, DSG1, GJA1, KANK2, KRT1, KRT16, KRT6C, KRT9, MBPTPS2, SERPINB7, TRPV3 | 4-8 |
nonepidermolytic | KRT16 | KRT16 | 4-8 |
NGS | BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 | BRCA1, BRCA2, CDKN2A, MEN1, PALB2, PALLD, PRSS1, TP53, SPINK1, STK11 | 4-8 |
- | CDKN2A | CDKN2A | 3-4 |
Pancreatic colipase deficiency | PNLIP | PNLIP | 2-4 |
PRSS1, SPINK1, CTRC | PRSS1, SPINK1, CTRC | 2-4 | |
PAPA syndrome | PSTPIP1/CD2BP1 | PSTPIP1/CD2BP1 | 2-3 |
SCN4A | SCN4A | 3-5 | |
PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 | PARK7 ATP13A2 PINK1 UCHL1 SNCA PARK2 CAV1/2 LRRK2 GCH1 | 2-3 | |
17 | VPS35 | VPS35 | 4-8 |
23, autosomal recessive, early onset | VPS13C | VPS13C | 4-8 |
infantile hypotonic | SLC18A2 | SLC18A2 | 4-8 |
juvenile, type 2 | PRKN | PRKN | 4-8 |
Parkinson disease | LRRK2 | LRRK2 | 4-8 |
Parkinson disease | diverse | diverse | 4-8 |
Parkinson disease | PINK1 | PINK1 | 4-8 |
Parkinson disease | PINK1 | PINK1 | 4-8 |
Parkinson disease 1, 4 | SNCA | SNCA | 4-8 |
PNKD | PNKD | 6-8 | |
NULL | |||
NULL | |||
mitochondrial | 3-4 | ||
Pelizaeus-Merzbacher-like disease | AIMP1 | AIMP1 | 5-7 |
Pelizaeus-Merzbacher-like disease | GJC2 | GJC2 | 4-5 |
Pelizaeus-Merzbacher-like disease | HSPD1 | HSPD1 | 4-5 |
PLP1 | PLP1 | 2-3 | |
PLP1 | PLP1 | 2-3 | |
SLC26A4 | SLC26A4 | 2-4 | |
- | SLC26A4 | SLC26A4 | 2-4 |
- | SLC26A4 | SLC26A4 | 2-4 |
- | SLC26A4 | SLC26A4 | 2-4 |
AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL | AP1S3, CARD14, CECR1, ELANE, FOXD3, HAX1, IL10, IL | 6-8 | |
- | AMHR2 | AMHR2 | 2-3 |
- | AMH, AMHR2 | AMH,AMHR2 | 3-4 |
- | AMH | AMH | 2-3 |
- | CYP1B1 | CYP1B1 | 2-4 |
- | PAX6 | PAX6 | 2-4 |
- | PITX2 | PITX2 | 2-4 |
glaucoma 1A | MYOC | MYOC | 2-4 |
PNMT | PNMT | NULL | |
PAH | PAH | ||
Schinzel type | WNT7A | WNT7A | 4-5 |
NULL | |||
Pierson syndrome | LAMB2 | LAMB2 | 2-4 |
NGS | ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 | ARNT2, CDON, GLI2, HESX1, LHX3, LHX4, OTX2, POU1F1, PROP1, RBM28, SOX2, SOX3 | 4-8 |
type 1 | POU1F1 | POU1F1 | 2-4 |
type 1 | LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR | LHX3, LHX4, GH1, HESX1, POU1F1, PROP1, GHRHR | 2-4 |
type 3 | LHX3 | LHX3 | 2-4 |
type 4 | LHX4 | LHX4 | 2-4 |
type 5 | HESX1 | HESX1 | 2-4 |
RUNX1 | RUNX1 | ||
autosomal recessive | PKHD1 | PKHD1 | 4-6 |
NULL | |||
- | ALG8 | ALG8 | 3-4 |
- | GANAB | GANAB | 3-4 |
- | PRKCSH | PRKCSH | 3-4 |
- | SEC63 | SEC63 | 3-4 |
AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 | AIRE, STAT3, FOXP3, ITCH, LRBA, IL2RA, STAT1, JAK1, CTLA4, STAT5b, SIRT1, TNFAIP3 | NULL | |
NGS | APC, MUTYH, NTHL1, POLD1, POLE | APC, MUTYH, NTHL1, POLD1, POLE | 4-6 |
NGS | BMPR1A, PTEN, SMAD4, STK11 | BMPR1A, PTEN, SMAD4, STK11 | 4-6 |
- | MUTYH | MUTYH | 4-8 |
- | MUTYH | MUTYH | 3-4 |
BICC1 | BICC1 | NULL | |
TSEN54 | TSEN54 | 3-4 | |
type 2A, 4, 5 | TSEN54 | TSEN54 | 3-4 |
type 1A | VRK1 | VRK1 | 3-4 |
NULL | |||
porencephaly 2 | COL4A2 | COL4A2 | 4-8 |
acute hepatic | ALAD | ALAD | 4-8 |
ALAD, HMBS, PPOX | ALAD,HMBS,PPOX | ||
HMBS | HMBS | ||
NULL | |||
NGS | 4-6 | ||
NGS | verschiedene Gene für CPEO | verschiedene Gene für CPEO | 4-6 |
4-6 | |||
NGS | AIP, DICER, MEN1, SDHB | AIP, DICER, MEN1, SDHB | 4-6 |
protein C receptor deficiency | PROCR | PROCR | 3-4 |
protoporphyria, erythropoietic | FECH | FECH | 8-20 |
- | WNK1 | WNK1 | 2-4 |
- | WNK4 | WNK4 | 2-4 |
- | WNK4 | WNK4 | 2-4 |
- | KLHL3 | KLHL3 | 2-4 |
purine nucleoside phosphorylse deficienc | PNP | PNP | 8-10 |
ALDH7A1 | ALDH7A1 | 2-4 | |
pyruvate carboxylase deficiency | PC | PC | 2-4 |
pyruvate kinase deficiency | PKLR | PKLR | 4-6 |
NULL | |||
FAM20C | FAM20C | 4-8 | |
HNF1B/TCF2 | HNF1B/TCF2 | 2-3 | |
NLRP7/NALP7, KHDC3L, MEI1, C11orf80 | NLRP7/NALP7, KHDC3L, MEI1, C11orf80 | ||
NULL | |||
NGS | 4-6 | ||
renal tubular acidosis, proximal | SLC4A4 | SLC4A4 | 2-4 |
CCDC66 | CCDC66 | 2-4 | |
verschiedene Gene für REDE | verschiedene Gene für REDE | 4-8 | |
- | RGS9BP | RGS9BP | 2-4 |
TMPRSS3 | TMPRSS3 | 3-4 | |
retinitis pigmentosa | USH3A | USH3A | 2-3 |
type 62 | MAK | MAK | 3-4 |
- | RB1 | RB1 | 4-6 |
- | RB1 | RB1 | 4-6 |
NGS | RB1, MYCN | RB1, MYCN | 4-8 |
X-linked, juvenile | RS1 | RS1 | 2-4 |
MECP2 | MECP2 | 3-4 | |
MECP2 | MECP2 | 3-4 | |
congenital variant | FOXG1 | FOXG1 | 3-4 |
congenital variant | FOXG1 | FOXG1 | 4-5 |
like | CDKL5 | CDKL5 | 3-4 |
like | CDKL5 | CDKL5 | 2-3 |
like | NTNG1 | NTNG1 | 3-4 |
NULL | |||
Rubinstein Taybi syndrome | CREBBP | CREBBP | 4-8 |
Rubinstein Taybi syndrome | CREBBP, EP300 | CREBBP, EP300 | 2-3 |
Rubinstein Taybi syndrome | CREBBP | CREBBP | 4-8 |
Rubinstein Taybi syndrome | EP300 | EP300 | 4-8 |
Rubinstein Taybi syndrome | CREBBP, EP300 | CREBBP, EP300 | 4-8 |
TWIST1 | TWIST1 | 2-3 | |
Sandhoff disease | HEXB | HEXB | 4-8 |
SMARCB1 | SMARCB1 | 2-4 | |
SCID and Omenn syndrome | RAG1 | RAG1 | 3-4 |
SCID and Omenn syndrome | RAG2 | RAG2 | 3-4 |
OXCT1 | OXCT1 | 2-4 | |
NPHP1, NPHP3, NPHP4, IQCB1, CEP290, SDCCAG8 | NPHP1, NPHP3,NPHP4, IQCB1,CEP290,SDCCAG8 | 4-8 | |
sepiapterin reductase deficiency | SPR | SPR | 2-3 |
SESAME sndrome | KCNJ10 | KCNJ10 | 3-4 |
NR5A1 | NR5A1 | 2-4 | |
- | AMXY | AMXY | 3-4 |
gonadal dysgenesis | NR0B1 | NR0B1 | 2-4 |
gonadal dysgenesis | NR0B1 | NR0B1 | 2-4 |
ASXL2 | ASXL2 | NULL | |
SHOX deficiency | SHOX | SHOX | 2-4 |
SHOX deficiency | SHOX | SHOX | 2-4 |
Shprintzen-Goldberg syndrome | SKI | SKI | 2-6 |
Shwachman-Diamond syndrome | SBDS | SBDS | 2-4 |
sialic acid storage disorder | SLC17A5 | SLC17A5 | 4-6 |
Simpson-Golabi-Behmel syndrome | GPC3 | GPC3 | 2-4 |
GPC3, GPC4 | GPC3,GPC4 | 2-4 | |
NGS | ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, EIF4A3, EVC, EVC2, GDF3, GDF6, GMNN, GNAI3, HAAO, HES7, KAT6B, KYNU, LFNG, LMX1B, MEOX1, MESP2, MNX1, MYO18B, NKX3-2, OFD1, ORC1, ORC4, ORC6, PLCB4, ....... | ABCC9, ALX1, ALX3, ALX4, BMPER, CDC45L, CDC6, CDT1, CILK1, DHODH, DLL3, EDN1, EDNRA, EFNB1, EFTUD2, | 4-6 |
Charlevoix-Saguenay type | SACS | SACS | 14-16 |
type 11 | SPG11 | SPG11 | 4-5 |
type 17 | BSCL2 | BSCL2 | 4-5 |
type 3 | ATL1 | ATL1 | 2-3 |
type 3 | ATL1 | ATL1 | 2-4 |
type 31 | REEP1 | REEP1 | 3-4 |
type 4 | SPAST | SPAST | 2-4 |
type 4 | SPAST | SPAST | 2-3 |
type 5 | CYP7B1 | CYP7B1 | 3-4 |
type 6 | NIPA1 | NIPA1 | NULL |
type 7 | SPG7 | SPG7 | 8-12 |
spermatogenic failure, AZF factor | USP9Y | USP9Y | 2-4 |
RAD51 | RAD51 | 2-4 | |
type 1 | IGHMBP2 | IGHMBP2 | 3-4 |
type 1, 2, 3, 4 | SMN1 | SMN1 | 3-4 |
type 1, 2, 3, 4 | SMN1 | SMN1 | 10-14 |
type 3 | SMN2 | SMN2 | 2-3 |
X-linked 2 | UBE1/UBA1 | UBE1/UBA1 | 5-6 |
4-6 | |||
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 | SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 | 3-4 | |
type 1 | SCA1/ATXN1 | SCA1/ATXN1 | 3-4 |
type 1 | SCA1/ATXN1 | SCA1/ATXN1 | 4-5 |
type 12 | SCA12/PPP2R2B | SCA12/PPP2R2B | 3-4 |
type 17 | TBP/SCA17 | TBP/SCA17 | 3-4 |
type 2 | ATXN2/SCA2 | ATXN2/SCA2 | 3-4 |
type 3 | ATXN3/SCA3 | ATXN3/SCA3 | 3-4 |
type 6 | CACNA1A/SCA6 | CACNA1A/SCA6 | 3-4 |
type 7 | ATXN7/SCA7 | ATXN7/SCA7 | 3-4 |
type 8 | SCA8 | SCA8 | 4-5 |
KCND3 | KCND3 | ||
FLNB | FLNB | 2-3 | |
FLNB | FLNB | 3-4 | |
FLNB | FLNB | 5-6 | |
congenital type | COL2A1 | COL2A1 | 4-6 |
congenital type | COL2A1 | COL2A1 | 4-6 |
congenital type | COL2A1 | COL2A1 | 2-3 |
type trada | TRAPPC2 | TRAPPC2 | 2-4 |
XYLT2 | XYLT2 | NULL | |
Statin therapy | SLCO1B1 | SLCO1B1 | 3-4 |
Statin therapy | SLCO1B1, ABCG2, ABCB1 | SLCO1B1, ABCG2, ABCB1 | 3-4 |
NGS | KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 | KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD and TP53 | 4-8 |
2-3 | |||
ALDH5A1 | ALDH5A1 | NULL | |
sucrase-isomaltase deficiency | SI | SI | 3-5 |
SOD2 | SOD2 | 4-6 | |
surfactant protein deficiency | ABCA3 | ABCA3 | 3-4 |
surfactant protein deficiency | ABCA3, SFTPC | ABCA3, SFTPC | 2-4 |
surfactant protein deficiency | SFTPB | SFTPB | 3-4 |
surfactant protein deficiency | SFTPB | SFTPB | 2-3 |
surfactant protein deficiency | SFTPC | SFTPC | 3-4 |
NGS | ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC | ABCA3, CSF2RA, CSF2RB, NKX2-1, SFTPB, SFTPC | 6-8 |
NULL | |||
PIP5K1C | PIP5K1C | NULL | |
MED13 | MED13 | ||
multiple | GDF5 | GDF5 | 3-4 |
systemic-onset juvenile idiopathic arthritis | IL6 | IL6 | 1-2 |
systemic-onset juvenile idiopathic arthritis | IL6 | IL6 | 1-2 |
PF4 | PF4 | NULL | |
HEXA | HEXA | 2-3 | |
HEXA | HEXA | 3-4 | |
AB variant | GM2A | GM2A | 4-5 |
NULL | |||
SLC19A2 | SLC19A2 | 2-4 | |
thiopurine methyltransferase deficiency | TPMT | TPMT | 3 |
- | ANKRD26 | ANKRD26 | 4-6 |
- | GATA1 | GATA1 | 4-6 |
NGS | 4-6 | ||
thrombotic thrombocytopenic purpura | ADAMTS13 | ADAMTS13 | 2-4 |
NGS | DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2, SLC26A4, SLC5A5, TG, THRA, THRB, TPO, TRH, TSHB, TSHR, TTF1, TTF2, UBR1 | DUOX2, DUOXA2, GLIS3, GNAS, IGSF1, IYD, LHX3, NKX2-1, NKX2-5, PAX8, POU1F1, PROP1, SECISBP2, SLC16A2 | 4-8 |
type 1 | DYT1 | DYT1 | 2-3 |
transaldolase deficiency | TALDO1 | TALDO1 | 6-8 |
Treacher Collins syndrome | POLR1C | POLR1C | 3-4 |
Treacher Collins syndrome | POLR1D | POLR1D | 3-4 |
Treacher Collins syndrome | TCOF1 | TCOF1 | 6-8 |
Treacher Collins syndrome | TCOF1 | TCOF1 | 2-3 |
trichothiodystrophy | MPLKIP | MPLKIP | 3-4 |
NGS | 4-6 | ||
PCGF2 | PCGF2 | ||
TAT | TAT | 4-6 | |
UL | UL | NULL | |
ANKS4B | ANKS4B | 2-4 | |
NGS | divers | divers | 4-8 |
type 1C | USH1C | USH1C | 2-4 |
type 1F | PCDH15 | PCDH15 | 2-4 |
type 1F | PCDH15 | PCDH15 | 2-4 |
type 1G | USH1G | USH1G | 2-4 |
type 1J | CIB2 | CIB2 | 2-4 |
type 2A | USH2A | USH2A | 2-4 |
type 2A | USH2A | USH2A | 2-4 |
type 2C | GPR98/ADGRV1 | GPR98/ADGRV1 | 2-4 |
type 3A | USH3A | USH3A | 2-3 |
type 3B | HARS | HARS | 2-4 |
type 48 | CIB2 | CIB2 | 3-4 |
NULL | |||
NULL | |||
ADA2 deficiency | CECR1/ADA2 | CECR1/ADA2 | 2-4 |
very long chain acyl-CoA dehydrogenase deficiency | ACADVL | ACADVL | 2-4 |
type 1A | CYP27B1 | CYP27B1 | 3-4 |
Type 1B | CYP2R1 | CYP2R1 | 3-4 |
VWF | VWF | 2-4 Wochen | |
EDNRB, NRTN | EDNRB, NRTN | 3-4 | |
- | EDN3 | EDN3 | 3-4 |
- | EDNRB | EDNRB | 3-4 |
SFXN4 | SFXN4 | NULL | |
GHRHR | GHRHR | 2-4 | |
- | WT1 | WT1 | 3-4 |
verschiedene Gene für WAGR | verschiedene Gene für WAGR | NULL | |
DDX11 | DDX11 | 3-4 | |
- | EZH2 | EZH2 | 2-4 |
- | NSD1 | NSD1 | 2-4 |
- | NSD1 | NSD1 | 2-4 |
Wiedemann-Steiner syndrome | KMT2A/MLL1 | KMT2A/MLL1 | 4-6 |
Williams Beuren syndrome | CLIP2, ELN, LIMK | CLIP2, ELN, LIMK | 3-4 |
- | REST | REST | 2-4 |
- | WT1 | WT1 | 2-4 |
- | WT1 | WT1 | 2-4 |
NGS | ATP7B | ATP7B | 2-4 |
Wilson disease | ATP7B | ATP7B | 2-4 |
Wilson disease | ATP7B | ATP7B | 2-4 |
Wolman disease | LIPA | LIPA | 3-4 |
DCAF17 | DCAF17 | NULL | |
WWP2 | WWP2 | ||
4-6 | |||
type 1 | XDH | XDH | 2-4 |
NGS | DDB2, ERCC1-5, POLH, XPA, XPC | DDB2,ERCC1-5, POLH, XPA, XPC | 4-8 |
diverse | diverse | 4-8 | |
8-12 | |||
transient neonatal | SLC30A2 | SLC30A2 | 4-6 |
¹ We offer molecular testing for all genes known for this disease. In some cases, specific genotype - phenotype correlations exist that allow for targeted testing. Please contact us.
² We offer linkage analysis where applicable (e. g., samples available from several family members, parental consanguinity) for prioritization of genes to be tested.
³ Step-by-step analysis
All Analysis are carried out in Ingelheim, exceptions are those marked with *, which are carried out in collaborating laboratories.